Spectral Medical Inc(EDT-T)
TSX

Today's Change
Real-Time Last Update
Day Low1.33
Day High1.35
Open:1.34
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
GlobeNewswire
Spectral Medical Announces U.S. FDA Filing of PMA Application for PMX
GlobeNewswire
Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders
GlobeNewswire
Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral’s Tigris Trial
GlobeNewswire
Spectral Medical Announces PMA Submission to U.S. FDA for PMX
GlobeNewswire
Spectral Medical Announces First Quarter 2026 Financial Results and Provides Corporate Update
Newsfile
Upcoming Meeting Dates - April 13, 2026
Newsfile
Spectral Medical Inc. Announces Participation in the 2026 Bloom Burton & Co. Healthcare Investor Conference
GlobeNewswire
Spectral Medical Announces Fourth Quarter and Fiscal 2025 Results and Provides Corporate Update
GlobeNewswire
Spectral Medical and Vantive Announce Publication of Complete Results from Spectral’s Tigris Trial in the Lancet Respiratory Medicine
Baystreet
Stocks in play: Spectral Medical Inc
GlobeNewswire
Spectral Medical Provides Update on PMA Submission Timing for PMX-20R
GlobeNewswire
Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
Spectral Medical Inc. Files Base Shelf Prospectus and Revised AIF
GlobeNewswire
Spectral Medical Announces Publication of EDEN Observational Study
GlobeNewswire
Spectral Medical Sponsors Unite for Sepsis Symposium, Chicago September 8 – 9, 2025
Baystreet
Stocks in play: Spectral Medical Inc.
GlobeNewswire
Spectral Medical Receives US$3 Million From Vantive
GlobeNewswire
Spectral Medical Announces Second Quarter and Provides Corporate Update
GlobeNewswire
Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders

Profile

Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the Toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. Its products include an endotoxin activity assay, a rapid in-vitro diagnostic test used to measure endotoxin levels in blood, and a polymyxin B hemoperfusion device designed to remove endotoxin from the bloodstream. The company's proprietary reagents include recombinant proteins, antibodies, and calibrators used in research and diagnostic applications.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.